JP2021504314A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021504314A5 JP2021504314A5 JP2020527906A JP2020527906A JP2021504314A5 JP 2021504314 A5 JP2021504314 A5 JP 2021504314A5 JP 2020527906 A JP2020527906 A JP 2020527906A JP 2020527906 A JP2020527906 A JP 2020527906A JP 2021504314 A5 JP2021504314 A5 JP 2021504314A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- kat
- compound according
- independently selected
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 C*C1CCOCC1 Chemical compound C*C1CCOCC1 0.000 description 12
- XDTMQSROBMDMFD-UHFFFAOYSA-N C1CCCCC1 Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- AIUUAKHKOQFCKF-UHFFFAOYSA-N CCC1COCC1 Chemical compound CCC1COCC1 AIUUAKHKOQFCKF-UHFFFAOYSA-N 0.000 description 1
- ATCIGAHWUUTLKA-UHFFFAOYSA-N CCCS1(C)C(C)NCC1 Chemical compound CCCS1(C)C(C)NCC1 ATCIGAHWUUTLKA-UHFFFAOYSA-N 0.000 description 1
- XLTFIQXBBLAFOT-UHFFFAOYSA-N CCC[N]1(C)C=C(CCCC(C)C)OCC1 Chemical compound CCC[N]1(C)C=C(CCCC(C)C)OCC1 XLTFIQXBBLAFOT-UHFFFAOYSA-N 0.000 description 1
- VJUXYFQNFGMPSV-UHFFFAOYSA-N CSC1=CNC=CC1 Chemical compound CSC1=CNC=CC1 VJUXYFQNFGMPSV-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762592215P | 2017-11-29 | 2017-11-29 | |
| US62/592,215 | 2017-11-29 | ||
| PCT/US2018/063110 WO2019108824A1 (en) | 2017-11-29 | 2018-11-29 | Myst family histone acetyltransferase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021504314A JP2021504314A (ja) | 2021-02-15 |
| JP2021504314A5 true JP2021504314A5 (https=) | 2022-01-06 |
Family
ID=66665802
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020527906A Pending JP2021504314A (ja) | 2017-11-29 | 2018-11-29 | Ｍｙｓｔファミリーヒストンアセチルトランスフェラーゼ阻害剤 |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US11685732B2 (https=) |
| EP (1) | EP3716964A4 (https=) |
| JP (1) | JP2021504314A (https=) |
| KR (1) | KR20200103005A (https=) |
| CN (1) | CN111565717A (https=) |
| AU (1) | AU2018375724A1 (https=) |
| BR (1) | BR112020010628A2 (https=) |
| CA (1) | CA3083616A1 (https=) |
| CL (1) | CL2020001447A1 (https=) |
| CO (1) | CO2020007895A2 (https=) |
| EA (1) | EA202091337A1 (https=) |
| IL (1) | IL274685A (https=) |
| MA (1) | MA51226A (https=) |
| MX (1) | MX2020007131A (https=) |
| SG (1) | SG11202004390VA (https=) |
| WO (1) | WO2019108824A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2022530097A (ja) | 2019-04-25 | 2022-06-27 | バイエル アクチェンゲゼルシャフト | がんを処置するためのアシルスルホンアミド類 |
| WO2021221444A1 (ko) * | 2020-04-27 | 2021-11-04 | 주식회사 오토텍바이오 | Ubr 박스 도메인 리간드로의 화합물 |
| CN112138162B (zh) * | 2020-09-29 | 2021-12-28 | 中国科学院动物研究所 | 降低kat7含量或活性的物质在预防衰老和治疗肝纤维化中的应用 |
| WO2022081842A1 (en) * | 2020-10-16 | 2022-04-21 | The Broad Institute, Inc. | Substituted acyl sulfonamides for treating cancer |
| WO2022081807A1 (en) * | 2020-10-16 | 2022-04-21 | The Broad Institute, Inc. | Substituted acyl sulfonamides for treating cancer |
| US20250145637A1 (en) | 2021-08-10 | 2025-05-08 | Jiangsu Hengrui Pharmaceuticals Co. Ltd. | Sulfonamide derivative, preparation method therefor and medical use thereof |
| MX2024005839A (es) | 2021-11-16 | 2024-06-26 | Insilico Medicine Ip Ltd | Inhibidores de lisina acetiltransferasa 6a (kat6a) y usos de los mismos. |
| AU2024217108A1 (en) | 2023-02-10 | 2025-09-18 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Crystalline form of sulfonamide derivative and preparation method therefor |
| KR20250155594A (ko) | 2023-03-16 | 2025-10-30 | 올레마 파마슈티컬스 인코포레이티드 | 아실설폰아마이드 kat6a 억제제 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4735959A (en) * | 1981-01-10 | 1988-04-05 | Dr. Karl Thomae Gmbh | Carboxylic acid amides and pharmaceutical compositions containing them |
| EP1014962A4 (en) | 1997-06-26 | 2007-06-27 | Lilly Co Eli | ANTITHROMBOTIC AGENTS |
| GB201510019D0 (en) * | 2015-06-09 | 2015-07-22 | Cancer Therapeutics Crc Pty Ltd | Compounds |
| AU2017367086A1 (en) * | 2016-11-29 | 2019-07-18 | Epizyme, Inc. | Compounds containing a sulfonic group as KAT inhibitors |
-
2018
- 2018-11-29 WO PCT/US2018/063110 patent/WO2019108824A1/en not_active Ceased
- 2018-11-29 SG SG11202004390VA patent/SG11202004390VA/en unknown
- 2018-11-29 CA CA3083616A patent/CA3083616A1/en active Pending
- 2018-11-29 JP JP2020527906A patent/JP2021504314A/ja active Pending
- 2018-11-29 EP EP18883537.5A patent/EP3716964A4/en not_active Withdrawn
- 2018-11-29 MX MX2020007131A patent/MX2020007131A/es unknown
- 2018-11-29 CN CN201880083981.7A patent/CN111565717A/zh active Pending
- 2018-11-29 MA MA051226A patent/MA51226A/fr unknown
- 2018-11-29 BR BR112020010628-3A patent/BR112020010628A2/pt not_active IP Right Cessation
- 2018-11-29 KR KR1020207018039A patent/KR20200103005A/ko not_active Ceased
- 2018-11-29 EA EA202091337A patent/EA202091337A1/ru unknown
- 2018-11-29 AU AU2018375724A patent/AU2018375724A1/en not_active Abandoned
- 2018-11-29 US US16/766,890 patent/US11685732B2/en active Active
-
2020
- 2020-05-14 IL IL274685A patent/IL274685A/en unknown
- 2020-05-29 CL CL2020001447A patent/CL2020001447A1/es unknown
- 2020-06-26 CO CONC2020/0007895A patent/CO2020007895A2/es unknown
-
2023
- 2023-02-16 US US18/170,319 patent/US20230357208A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021504314A5 (https=) | ||
| CN113874350A (zh) | 作为缺氧可诱导因子-2(α)抑制剂的四氢-1H-环戊[CD]茚衍生物 | |
| JP2020517707A5 (https=) | ||
| JP2018538248A5 (https=) | ||
| JP5576485B2 (ja) | 新生物疾患又は自己免疫疾患を処置するためのプロドラッグとしてのフラザノベンゾイミダゾール | |
| JP2005535586A5 (https=) | ||
| EP2914591B1 (en) | Inhibitors of cytomegalovirus | |
| JP2008511601A5 (https=) | ||
| JP2018535967A5 (https=) | ||
| WO2012161965A1 (en) | Novel imidazole derivatives useful for the treatment of arthritis | |
| JP2010504346A5 (https=) | ||
| ME02502B (me) | Modulator glukagonskog receptora | |
| JP2016518437A5 (https=) | ||
| JP2009536620A5 (https=) | ||
| JP2019527724A5 (https=) | ||
| JP2005534669A5 (https=) | ||
| JPH03106879A (ja) | アザベンズイミダゾール化合物 | |
| JP2013532652A5 (https=) | ||
| RU2010143455A (ru) | Имидазохинолины и производные пиримидина в качестве потенциальных модуляторов vegf-стимулируемых ангиогенных процессов | |
| JP2007502295A5 (https=) | ||
| JP2015536997A5 (https=) | ||
| CZ243093A3 (en) | Benzofuran derivatives, process of their preparation and pharmaceutical preparations in which they are comprised | |
| RU2009123525A (ru) | ПРОИЗВОДНЫЕ 5-СУЛЬФАНИЛМЕТИЛ[1,2,4}ТРИАЗОЛ[1,5-а]ПИРИМИДИН-7-ОЛА В КАЧЕСТВЕ АНТАГОНИСТОВ CXCR2 | |
| JP2021500332A5 (https=) | ||
| JP2016525104A5 (https=) |